Sartorius AG (OTCPK:SARTF)
$ 197.235 0 (0%) Market Cap: 17.02 Bil Enterprise Value: 21.35 Bil PE Ratio: 178.54 PB Ratio: 5.11 GF Score: 91/100

Q3 2024 Sartorius AG and Sartorius Stedim Biotech SA Earnings Call Transcript

Oct 17, 2024 / 11:00AM GMT
Release Date Price: $197.24
Operator

Ladies and gentlemen, welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the 9 months 2024 Results. I am Serge, the Chorus Call operator. (Operator Instructions) And the conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Dr. Joachim Kreuzburg. Please go ahead, sir.

Joachim Kreuzburg
Sartorius AG and Sartorius Stedim Biotech SA - IR

Yes. Thank you very much. Welcome, everyone. Good day, and a pleasure to walk you through our results for the first 9 months of 2024. As always, we will do this together. That means it's myself and Florian Funck, CFO of the Sartorius Group as well as René Fáber, CEO of Sartorius Stedim Biotech, and we will start with the results of Sartorius AG or the Sartorius Group, and then thereafter we will walk you through the additional information on Sartorius Stedim Biotech.

So let me start with highlighting the key results of the first 9 months of 2024. And I think the 2 main points here are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot